Our findings that P2RY13 expression correlates with an immunostimulatory DCs phenotype and enhanced T cell activation align with this paradigm, suggesting that modulating P2RY13 signaling could be a viable strategy to reinvigorate the anti-tumor immune response. This evidence concerns the gene P2RY13 and neoplasm.